UnknownPhase 4

Neurocognitive Outcome Assesment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial.

90 participantsStarted 2017-06

Plain-language summary

Who can participate

Age range20 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * preoptic meningioma, not recurrent, size is operative. Exclusion Criteria: * other meningiomas than preoptic , recurrent cases, size is not operative, other medical conditions affect the mental condition of the patient.

What they're measuring

Neurocognitive Outcome Assessment using MOCA scale

Timeframe: 1 year

Trial details

NCT IDNCT03190122

SponsorKasr El Aini Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-04

View on ClinicalTrials.gov More Neurocognitive Outcome Assesment in Patients With Perioptic Meningiomas trials